Scientists hunt for protein clues in severe dry eye treatment
NCT ID NCT07632534
First seen Jun 27, 2026 · Last updated Jul 10, 2026 · Updated 2 times
Summary
This study aims to understand why some patients with severe dry eye syndrome improve with autologous serum eye drops while others do not. Researchers will analyze the protein makeup of the drops from 68 participants over 6 months. The goal is to identify which proteins are linked to a good response, which could lead to more personalized treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CHU de Saint-Etienne
RECRUITINGSaint-Etienne, 42055, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can insulin eye drops quench dry eyes?
- Can a new eye drop soothe severe dry eye?
- New imaging tools put to the test for measuring dry eye treatment effects
- Fewer drops, same relief? trial tests Twice-Daily systane complete against standard Four-Times-Daily regimen
- Could a special screen light reduce tired eyes and dryness?
- Nasal spray could make contact lenses more comfortable